During the past decade, Florida Cancer Specialist conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialist" are "Advanced Solid Tumor" (1 trials), "Non Small Cell Lung Cancer Metastatic" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Florida Cancer Specialist" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialist" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "DRP-104" (1 trials), "atezolizumab" (1 trials), "binimetinib" (1 trials) and "encorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialist" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Florida Cancer Specialist". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Florida Cancer Specialist, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialist, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".